Astroglial cytoprotection by erythropoietin pre-conditioning: Implications for ischemic and degenerative CNS disorders

Journal of Neurochemistry

Volumn 93, Issue 2, 2005, Pages 392-402

  Diaz, Zuanel ^a   Assaraf, Michael I ^a   Miller Jr , Wilson H ^a,c   Schipper, Hyman M ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Astrocytes; Cytoprotection; Erythropoietin; Heme oxygenase 1; Oxidative stress

Indexed keywords

ARSENIC TRIOXIDE; HEME OXYGENASE 1; MESOPORPHYRIN TIN; NITRIC OXIDE; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; STAUROSPORINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; ATTENUATION; BRAIN ISCHEMIA; CELL DEATH; CELL PROTECTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; GENE INDUCTION; INCUBATION TIME; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ASTROCYTES; CELL HYPOXIA; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM DISEASES; CYTOPROTECTION; ERYTHROPOIETIN; ISCHEMIC PRECONDITIONING; NEURODEGENERATIVE DISEASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 17444386695     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03038.x     Document Type: Article

References (75)

1. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M. L. and Ghezzi P. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952, 128-134.
2. Appleton S. D., Chretien M. L., McLaughlin B. E., Vreman H. J., Stevenson D. K., Brien J. F., Nakatsu K., Maurice D. H. and Marks G. S. (1999) Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab. Dispos. 27, 1214-1219.
3. Aschner M. (2000) Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels. Neurotoxicology 21, 1101-1107.
4. Ashley R. A., Dubuque S. H., Dvorak B., Woodward S. S., Williams S. K. and Kling P. J. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 51, 472-478.
5. Assandri R., Egger M., Gassmann M., Niggli E., Bauer C., Forster I. and Gorlach A. (1999) Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J. Physiol. 516, 343-352.
6. Assaraf M. I., Liberman A., Bennett D., Miller W. H. and Schipper H. M. (2004) Up-regulation of erythropoietin receptor expression in AD and MCI astroglia. Neurobiol. Aging 25, S546.
7. Baranano D. E. and Snyder S. H. (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl Acad. Sci. USA 98, 10 996-11 002.
8. Beltran B., Mathur A., Duchen M. R., Erusalimsky J. D. and Moncada S. (2000) The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc. Natl Acad. Sci. USA 97, 14 602-14 607.
9. Bernaudin M., Marti H. H., Roussel S., Divoux D., Nouvelot A., MacKenzie E. T. and Petit E. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643-651.
10. Bernaudin M., Bellail A., Marti H. H., Yvon A., Vivien D., Duchatelle I., Mackenzie E. T. and Petit E. (2000) Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271-278.
11. Brines M. L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N. C., Cerami C, Itri L. M. and Cerami A. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl Acad. Sci. USA 97, 10 526-10 531.
12. Calo L. A., Stanic L., Davis P. A., Pagnin E., Munaretto G., Fusaro M., Landini S., Semplicini A. and Piccoli A. (2003) Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients. Int. J. Clin. Pharmacol. Ther. 41, 187-192.
13. Campana W. M. and Myers R. R. (2003) Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur. J. Neurosci. 18, 1497-1506.
14. Celik M., Gokmen N., Erbayraktar S. et al. (2002) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl Acad. Sci. USA 99, 2258-2263.
15. Cerami A., Brines M., Ghezzi P., Cerami C. and Itri L. M. (2002) Neuroprotective properties of epoetin alfa. Nephrol Dial. Transplant. 17, 8-12.
16. Chen H. C., Tsai J. C., Tsai J. H. and Lai Y. H. (1997) Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients. Kidney Int. 52, 1390-1394.
17. Chong Z. Z., Kang J. Q. and Maiese K. (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979.
18. Chopra V. S., Chalifour L. E. and Schipper H. M. (1995) Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells. Brain Res. Mol. Brain Res. 31, 173-184.
19. Chopra V. S., Moozar K. L., Mehindate K. and Schipper H. M. (1997) A cellular stress model for the differential expression of glial lysosomal cathepsins in the aging nervous system. Exp. Neurol. 147, 221-228.
20. Clark A. S., West K., Streicher S. and Dennis P. A. (2002) Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707-717.
21. Damen J. E., Mui A. L., Puil L., Pawson T. and Krystal G. (1993) Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81, 3204-3210.
22. Dennery P. A. (2000) Regulation and role of heme oxygenase in oxidative injury. Curr. Top. Cell Regul. 36, 181-199.
23. Digicaylioglu M. and Lipton S. A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641-647.
24. Dore S., Takahashi M., Ferns C. D., Zakhary R., Hester L. D., Guastella D. and Snyder S. H. (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA 96, 2445-2450.
25. Dwyer B. E., Nishimura R. N. and Lu S. Y. (1995) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res. Mol. Brain Res. 30, 37-47.
26. Ehrenreich H., Hasselblatt M., Dembowski C et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495-505.
27. Ehrenreich H., Degner D., Meller J. et al. (2004) Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol. Psychiat. 9, 42-54.
28. Eid T. and Brines M. (2002) Recombinant human erythropoietin for neuroprotection: what is the evidence? Clin. Breast Cancer 3, S109-S115.
29. Erbayraktar S., Grasso G., Sfacteria A. et al. (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl Acad. Sci. USA 100, 6741-6746.
30. Gebbia V., Di Marco P. and Citarrella P. (2003) Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin. Crit. Rev. Oncol. Hematol. 48, S49-S55.
31. Gene S., Akhisaroglu M., Kuralay F. and Gene K. (2002) Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci. Lett. 321, 73-76.
32. Gong J., Traganos F. and Darzynkiewicz Z. (1994a) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319.
33. Gong J., Traganos F. and Darzynkiewicz Z. (1994b) Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points. Cancer Res. 54, 3136-3139.
34. Hardin J. A., Sherr D. H., DeMaria M. and Lopez P. A. (1992) A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J. Immunol. Meth. 154, 99-107.
35. Hertz L. (2003) Non-Neuronal Cells of the Nervous System: Function and Dysfunction/Part II: Biochemistry, Physiology and Pharmacology, Vol. 31. Molecular and Cell Biology, Elsevier, Amsterdam.
36. Ihle J. N. (1995) Cytokine receptor signalling. Nature 377, 591-594.
37. Jelkmann W. (1994) Biology of erythropoietin. Clin. Invest. 72, S3-S10.
38. Juhaszova M., Zorov D. B., Kim S. H. et al. (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113, 1535-1549.
39. Junk A. K., Mammis A., Savitz S. I., Singh M., Roth S., Malhotra S., Rosenbaum P. S., Cerami A., Brines M. and Rosenbaum D. M. (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 99, 10 659-10 664.
40. Kawakami M., Sekiguchi M., Sato K., Kozaki S. and Takahashi M. (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276, 39 469-39 475.
41. Krantz S. B. (1991) Erythropoietin. Blood 77, 419-434.
42. Kulkami G. V. and McCulloch C. A. (1994) Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. J. Cell Sci. 107, 1169-1179.
43. Lewczuk P., Hasselblatt M., Kamrowski-Kruck H., Heyer A., Unzicker C., Siren A. L. and Ehrenreich H. (2000) Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 11, 3485-3488.
44. Llesuy S. F. and Tomaro M. L. (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta 1223, 9-14.
45. Macdougall I. C. (2003) Erythropoietin and renal failure. Curr. Hematol. Rep. 2, 459-464.
46. Manganaro F., Chopra V. S., Mydlarski M. B., Bernatchez G. and Schipper H. M. (1995) Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radic. Biol. Med. 19, 823-835.
47. Marti H. H., Gassmann M., Wenger R. H., Kvietikova I., Morganti-Kossmann M. C., Kossmann T., Trentz O. and Bauer C. (1997) Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 51, 416-418.
48. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M. and Sasaki R. (1994) A novel site of erythropoietin production. Oxygendependent production in cultured rat astrocytes. J. Biol. Chem. 269, 19 488-19 493.
49. Meggio F., Donella Deana A., Ruzzene M. et al. (1995) Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur. J. Biochem. 234, 317-322.
50. Mehindate K., Sahlas D. J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S. and Schipper H. M. (2001) Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77, 1386-1395.
51. Morishita E., Masuda S., Nagao M., Yasuda Y. and Sasaki R. (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116.
52. Nagai A., Nakagawa E., Choi H. B., Hatori K., Kobayashi S. and Kim S. U. (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60, 386-392.
53. Nakagami T., Toyomura K., Kinoshita T. and Morisawa S. (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta 1158, 189-193.
54. Namgung U. and Xia Z. (2001) Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 174, 130-138.
55. Nunomura A., Perry G., Aliev G. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
56. Pratico D., Clark C. M., Liun F., Rokach J., Lee V. Y. and Trojanowski J. Q. (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59, 972-976.
57. Ryter S. W. and Tyrrell R. M. (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 28, 289-309.
58. Sadamoto Y, Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S. and Sasaki R. (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253, 26-32.
59. Sakanaka M., Wen T. C., Matsuda S., Masuda S., Morishita E., Nagao M. and Sasaki R. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl Acad. Sci. USA 95, 4635-4640.
60. Sawyer S. T. and Penta K. (1994) Erythropoietin cell biology. Hematol. Oncol. Clin. North Am. 8, 895-911.
61. Schipper H. M. (2004) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann. NY Acad. Sci. 1012, 84-93.
62. Schipper H. M., Cisse S. and Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758-768.
63. Schipper H. M., Bernier L., Mehindate K. and Frankel D. (1999) Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J. Neurochem. 72, 1802-1811.
64. Sinor A. D. and Greenberg D. A. (2000) Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci. Lett. 290, 213-215.
65. Siren A. L. and Ehrenreich H. (2001 ) Erythropoietin - a novel concept for neuroprotection. Eur. Arch. Psychiat. Clin. Neurosci. 251, 179-184.
66. Siren A. L., Knerlich F., Poser W., Gleiter C. H., Bruck W. and Ehrenreich H. (2001a) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. (Berl.) 101, 271-276.
67. Siren A. L., Fratelli M., Brines M. et al. (2001b) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 4044-4049.
68. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N. and Ames B. N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046.
69. Sugawa M., Sakurai Y., Ishikawa-Ieda Y., Suzuki H. and Asou H. (2002) Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44, 391-403.
70. Swanson R. A., Ying W. and Kauppinen T. M. (2004) Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4, 193-205.
71. Vairano M., Dello Russo C., Pozzoli G., Battaglia A., Scambia G., Tringali G., Aloe-Spiriti M. A., Preziosi P. and Navarra P. (2002) Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 16, 584-592.
72. Verbeke P., Fonager J., Clark B. F. and Rattan S. I. (2001) Heat shock response and ageing: mechanisms and applications. Cell Biol. Int. 25, 845-857.
73. Weber A., Maier R. F., Hoffmann U., Grips M., Hoppenz M., Aktas A. G., Heinemann U., Obladen M. and Schuchmann S. (2002) Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures. Brain Res. 958, 305-311.
74. Weishaupt J. H., Rohde G., Polking E., Siren A. L., Ehrenreich H. and Bahr M. (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 45, 1514-1522.
75. Zachee P., Ferrant A., Daelemans R., Coolen L., Goossens W., Lins R. L., Couttenye M., De Broe M. E. and Boogaerts M. A. (1993) Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment. Nephron 65, 288-293.